Seroepidemiological study of pertussis in Henan Province, China, and prediction of the effectiveness of a new immunization strategy

中国河南省百日咳血清流行病学研究及新型免疫策略有效性预测

阅读:1

Abstract

The study objectives were to analyze the epidemiological characteristics of pertussis in Henan Province, China, and to evaluate the impact of pertussis vaccination strategy adjustments on population infection rates. A retrospective analysis was conducted on the reported pertussis cases in Henan Province from 2012 to 2024. The concentration of IgG antibodies against pertussis toxin (anti-PT IgG) was measured in 18,528 healthy individuals from 2022 to 2024. The positive rate (≥20 IU/mL) and median concentration (MC) were calculated, and the infection rate was estimated based on anti-PT IgG ≥ 40 IU/mL, using the susceptible-exposed-infectious-recovered-vaccinated (SEIRV) model to predict the effect of adding a pertussis booster dose at 6 years. The average annual incidence of pertussis in Henan Province from 2012 to 2024 was 2.21 per 100,000 population. The overall anti-PT IgG positivity rate was 16.42 %, and the MC was 4.66 IU/mL. The antibody concentration is influenced by age, gender, and vaccine type. The population that completed the full course of vaccination had the highest anti-PT IgG positive rate (17.81 %) and the highest MC (4.97 IU/mL). The population that vaccinated the diphtheria-tetanus-acellular pertussis-inactivated polio vaccine-haemophilus influenzae type b (DTaP-IPV/ Hib) had the highest MC (14.83 IU/mL). The total estimated infection rate of pertussis was 7,833.45 per 100,000, peaking in the 6-year age group (10,809.72 per 100,000). When the estimated coverage rate of the pertussis booster vaccination reaches 83.21 %, the infection rate could be decreased by 71.41 %. The incidence of pertussis in Henan Province has increased, and the infection rate is higher than anticipated. Booster immunization at age six can significantly lower the risk of infection.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。